XTENZEON Trademark

Trademark Overview

On Tuesday, July 26, 2022, a trademark application was filed for XTENZEON with the United States Patent and Trademark Office. The USPTO has given the XTENZEON trademark a serial number of 97520170. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, August 14, 2024. This trademark is owned by Merck Sharp & Dohme LLC. The XTENZEON trademark is filed in the Pharmaceutical Products category with the following description:

Human vaccine preparations
xtenzeon

General Information

Serial Number97520170
Word MarkXTENZEON
Filing DateTuesday, July 26, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, August 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 20, 2023

Trademark Statements

Goods and ServicesHuman vaccine preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 17, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMerck Sharp & Dohme LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressRahway, NJ 07065
Party NameMerck Sharp & Dohme LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressRahway, NJ 07065

Trademark Events

Event DateEvent Description
Monday, May 15, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 29, 2022NEW APPLICATION ENTERED
Wednesday, August 17, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 11, 2023ASSIGNED TO EXAMINER
Wednesday, May 31, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 20, 2023PUBLISHED FOR OPPOSITION
Tuesday, June 20, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 15, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 26, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 1, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 26, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 26, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 26, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, January 26, 2024SOU TEAS EXTENSION RECEIVED
Friday, January 26, 2024SOU EXTENSION 1 FILED
Friday, January 26, 2024SOU EXTENSION 1 GRANTED
Tuesday, January 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 1, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, March 1, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 14, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, August 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 14, 2024SOU EXTENSION 2 GRANTED
Wednesday, August 14, 2024SOU EXTENSION 2 FILED
Friday, March 1, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 1, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED

Related Keywords

xtenzeon preparations vaccine human